Omixon Launches NanoTYPETM RUO, a Multiplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore’s MinIONTM Platform and Enters into an Agreement with Oxford Nanopore Technologies

High resolution histocompatibility testing for urgent transplant cases made possible within five hours turnaround time. Budapest, Hungary, September 27, 2022. Omixon Biocomputing, Ltd announced today the launch of NanoTYPETM RUO, a multiplex 11 loci human leukocyte antigen (HLA) amplification kit and the complementary NanoTYPERTM software compatible with Oxford Nanopore’s...

 

Read more

BSHI 2022

  BSHI 2022 | British Society for Histocompatibility and Immunogenetics Conference | 13-14 Sept, 2022, London, UK    The opportunity to meet us again is open, as Omixon team will be present at the 32nd  Annual British Society for Histocompatibility and Immunogenetics Conference in London, UK. Our experts are looking...

 

Read more